Prestigious journal publishes paper on Dendrite/IFSO Global Registry Report
Dendrite Clinical Systems is pleased to announce the prestigious journal, Obesity Surgery, has published a paper highlighting international bariatric surgery practice from the 4th Dendrite/IFSO Global Registry Report. The paper, ‘Bariatric Surgery Worldwide: Baseline Demographic Description and One-Year Outcomes from the Fourth Dendrite/IFSO Global Registry Report 2018’, (Himpens et al. Obesity Surgery. March 2019. Volume 29, Issue 3, pp 782–795), stated that the registry has amalgamated data from 51 different countries, 14 of which provided data from their national registries. Data were available from 394,431 individual records including:
- 72,645 Roux en Y gastric bypass operations (38.2%)
- 87,467 sleeve gastrectomy operations (46.0%)
- 14,516 one anastomosis gastric bypass procedures (7.6%) and;
- 9,534 gastric banding operations (5.0%)
The Dendrite/IFSO Global Registry Report is the culmination of years of research and analyses from the IFSO Global Registry Project, which was established in January 2014 to demonstrate that it is possible to merge and analyse bariatric and metabolic surgical data from different countries and centres. The registry has been running on Dendrite's Intellect Web Software Platform for the last six years.
“I would like to congratulate the authors on their excellent paper summarising the key findings from the latest report,” said Dr Peter Walton, Dendrite Clinical Systems. “The Dendrite/IFSO Global Registry Project continues to garner great interest from bariatric and metabolic surgeons from all over the world and we will be publishing/launching the fifth report in Madrid in September 2019.”
To access the paper, please click here.
Dendrite Clinical Systems is delighted to report that our Managing Director, Dr Peter Walton, has published a chapter discussing the value of clinical registries in new publication on Laparoscopic Sleeve Gastrectomy (LSG). In his Chapter, Dr Peter Walton outlines value of national bariatric registries and their capability to deliver evidence on a global basis, as well as providing some practical perspectives on best practice when setting out to start a national registry and how to keep a good registry going.
Dendrite Clinical Systems and the Institute for Health Research (IGES) in Berlin, Germany, have initiated the Outpatient Treatment of COVID-19 Infections (ABC-19) study, to record data on the treatment of COVID-19 patients and discover more about the outpatient course of the disease, the individual risk factors of patients that contribute to severe COVID-19 courses and the procedures of general practitioners (GPs).
Researchers at the University College London and University College London Hospitals NHS Foundation Trust), London, UK, have reported that the vast majority of participants with new onset loss of smell were positive for COVID19, and this acute loss of sense of smell needs to be considered globally as a criterion for self-isolation, testing and contact tracing in order to contain the spread of COVID-19.
Dendrite Clinical Systems’ innovative “Intellect Web” software has been chosen by an international group of 17 leading diabetes experts from the multidisciplinary Diabetes Surgery Summit (DSS), as the platform on which the CoviDiab project will establish a Global Registry to collect new cases of diabetes in patients with COVID-19.


